Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Eton Pharmaceuticals (ETON) over the last 3 years, with Q3 2025 value amounting to -$28000.0.

  • Eton Pharmaceuticals' Tax Provisions rose 7777.78% to -$28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $199000.0, marking a year-over-year increase of 1371.43%. This contributed to the annual value of $15000.0 for FY2024, which is 9392.71% down from last year.
  • Eton Pharmaceuticals' Tax Provisions amounted to -$28000.0 in Q3 2025, which was up 7777.78% from $66000.0 recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Tax Provisions peaked at $247000.0 during Q4 2023, and registered a low of -$126000.0 during Q3 2024.
  • Moreover, its 3-year median value for Tax Provisions was $66000.0 (2025), whereas its average is $53428.6.
  • Per our database at Business Quant, Eton Pharmaceuticals' Tax Provisions crashed by 6477.73% in 2024 and then surged by 7777.78% in 2025.
  • Over the past 3 years, Eton Pharmaceuticals' Tax Provisions (Quarter) stood at $247000.0 in 2023, then tumbled by 64.78% to $87000.0 in 2024, then plummeted by 132.18% to -$28000.0 in 2025.
  • Its last three reported values are -$28000.0 in Q3 2025, $66000.0 for Q2 2025, and $74000.0 during Q1 2025.